The EuroMeeting and Clinical Forum will take place in Paris as planned, in spite of January’s terrorist attacks in the French capital.
The EuroMeeting and Clinical Forum will take place in Paris as planned, in spite of January’s terrorist attacks in the French capital, according to the Drug Information Association (DIA).
“We are working closely with the venue and the city of Paris to make sure all security measures are taken and onsite security will be reinforced,” noted Natacha Scholl, Team Leader of Operations for DIA in Europe, Middle East & Africa. “We will put everything in place to reassure participants of course.”
She does not anticipate that the attacks will have any great impact on delegate numbers. “Registrations haven't stopped over the past days, despite the tragic events,” she remarked.
As of January 15, there were already more than 650 registered participants, and Scholl said the organizers are expecting at least 2500 to 3000 attendees in total for the two events.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.